Drug
Doxirazole
Doxirazole: highest development phase Phase 1, developed by Hikma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hikma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Doxirazole NCT02529787 | Phase 1 | Healthy |
Latest
No recent events.
Follow Doxirazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.